Literature DB >> 24038088

LAT1 is a critical transporter of essential amino acids for immune reactions in activated human T cells.

Keitaro Hayashi1, Promsuk Jutabha, Hitoshi Endou, Hironori Sagara, Naohiko Anzai.   

Abstract

Activation of T cells accompanies remarkable enhancement of metabolism. Sufficient and continuous nutrient supply is therefore important to support immune reaction in T cells. However, the mechanism of the promotion of nutrient incorporation in activated T cells has not been elucidated. In this study, we show that L-type amino acid transporter 1 (LAT1) is a major transporter for essential amino acids into activated human T cells. CD3/CD28 stimulation in primary human T cells triggered dramatic induction of LAT1 expression mediated by NF-κB and AP-1. Functional disturbance of LAT1 by a specific inhibitor and by small interfering RNA in human T cells suppressed essential amino acid uptake and induced a stress response mediated by DNA damage-inducible transcript 3 to attenuate cytokine production via inhibition of NF-κB and NFAT activities. These results uncover the previously unknown mechanism by which T cells accelerate essential amino acid uptake upon activation and adapt to essential amino acid starvation. Our results also raise the possibility for application of an LAT1 inhibitor as a new drug for therapy of disease caused by exaggerated immune response.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24038088     DOI: 10.4049/jimmunol.1300923

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

Review 1.  Immunometabolism of T cells and NK cells: metabolic control of effector and regulatory function.

Authors:  Sophie M Poznanski; Nicole G Barra; Ali A Ashkar; Jonathan D Schertzer
Journal:  Inflamm Res       Date:  2018-07-31       Impact factor: 4.575

Review 2.  Regulation of T cell immunity by cellular metabolism.

Authors:  Zhilin Hu; Qiang Zou; Bing Su
Journal:  Front Med       Date:  2018-08-16       Impact factor: 4.592

Review 3.  Hypoxia and cellular metabolism in tumour pathophysiology.

Authors:  Scott K Parks; Yann Cormerais; Jacques Pouysségur
Journal:  J Physiol       Date:  2017-02-19       Impact factor: 5.182

4.  A Combined Omics Approach to Generate the Surface Atlas of Human Naive CD4+ T Cells during Early T-Cell Receptor Activation.

Authors:  Anke Graessel; Stefanie M Hauck; Christine von Toerne; Edda Kloppmann; Tatyana Goldberg; Herwig Koppensteiner; Michael Schindler; Bettina Knapp; Linda Krause; Katharina Dietz; Carsten B Schmidt-Weber; Kathrin Suttner
Journal:  Mol Cell Proteomics       Date:  2015-05-19       Impact factor: 5.911

5.  HOXB9 acts as a negative regulator of activated human T cells in response to amino acid deficiency.

Authors:  Keitaro Hayashi; Motoshi Ouchi; Hitoshi Endou; Naohiko Anzai
Journal:  Immunol Cell Biol       Date:  2016-03-01       Impact factor: 5.126

6.  Towards antigen-specific Tregs for type 1 diabetes: Construction and functional assessment of pancreatic endocrine marker, HPi2-based chimeric antigen receptor.

Authors:  Ilian A Radichev; Jeongheon Yoon; David W Scott; Kurt Griffin; Alexei Y Savinov
Journal:  Cell Immunol       Date:  2020-09-30       Impact factor: 4.868

Review 7.  Immunometabolism in the Single-Cell Era.

Authors:  Maxim N Artyomov; Jan Van den Bossche
Journal:  Cell Metab       Date:  2020-10-06       Impact factor: 27.287

8.  GCN2 is essential for CD8+ T cell survival and function in murine models of malignant glioma.

Authors:  Aida Rashidi; Jason Miska; Catalina Lee-Chang; Deepak Kanojia; Wojciech K Panek; Aurora Lopez-Rosas; Peng Zhang; Yu Han; Ting Xiao; Katarzyna C Pituch; Julius W Kim; Mahsa Talebian; Jawad Fares; Maciej S Lesniak
Journal:  Cancer Immunol Immunother       Date:  2019-12-16       Impact factor: 6.968

9.  L-type amino-acid transporter 1 (LAT1): a therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma/T-cell acute lymphoblastic leukemia.

Authors:  C Rosilio; M Nebout; V Imbert; E Griessinger; Z Neffati; J Benadiba; T Hagenbeek; H Spits; J Reverso; D Ambrosetti; J-F Michiels; B Bailly-Maitre; H Endou; M F Wempe; J-F Peyron
Journal:  Leukemia       Date:  2014-12-08       Impact factor: 11.528

Review 10.  Insight into the role of mTOR and metabolism in T cells reveals new potential approaches to preventing graft rejection.

Authors:  Ying-Chun Lo; Chen-Fang Lee; Jonathan D Powell
Journal:  Curr Opin Organ Transplant       Date:  2014-08       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.